These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20870804)

  • 1. Urotensin II receptor antagonist attenuates monocrotaline-induced cardiac hypertrophy in rats.
    Gao S; Oh YB; Shah A; Park WH; Chung MJ; Lee YH; Kim SH
    Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1782-9. PubMed ID: 20870804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urantide improves the structure and function of right ventricle as determined by echocardiography in monocrotaline-induced pulmonary hypertension rat model.
    Wang Y; Tian W; Xiu C; Yan M; Wang S; Mei Y
    Clin Rheumatol; 2019 Jan; 38(1):29-35. PubMed ID: 29362961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-(1-7) stimulates high atrial pacing-induced ANP secretion via Mas/PI3-kinase/Akt axis and Na+/H+ exchanger.
    Shah A; Gul R; Yuan K; Gao S; Oh YB; Kim UH; Kim SH
    Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1365-74. PubMed ID: 20190099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urotensin II stimulates high frequency-induced ANP secretion via PLC-PI 3K-PKC pathway.
    Gao S; Shah A; Oh YB; Park WH; Kim SH
    Peptides; 2010 Jan; 31(1):164-9. PubMed ID: 19896516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of negatively regulated ANP secretion by calcium in hypertrophied atria.
    Kim SH; Cao C; Han JH; Kim SZ; Cho KW
    Regul Pept; 2002 May; 105(3):181-8. PubMed ID: 11959372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
    Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
    Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urotensin II and urotensin II-related peptide (URP) in cardiac ischemia-reperfusion injury.
    Prosser HC; Forster ME; Richards AM; Pemberton CJ
    Peptides; 2008 May; 29(5):770-7. PubMed ID: 17900760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis.
    Bruce E; Shenoy V; Rathinasabapathy A; Espejo A; Horowitz A; Oswalt A; Francis J; Nair A; Unger T; Raizada MK; Steckelings UM; Sumners C; Katovich MJ
    Br J Pharmacol; 2015 May; 172(9):2219-31. PubMed ID: 25522140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac atrial natriuretic peptide in monocrotaline-induced pulmonary hypertensive rats.
    Ohie T; Kikuchi K; Watanabe K; Mori C
    Acta Paediatr Jpn; 1993 Aug; 35(4):278-82. PubMed ID: 8379317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urantide alleviates monocrotaline induced pulmonary arterial hypertension in Wistar rats.
    Mei Y; Jin H; Tian W; Wang H; Wang H; Zhao Y; Zhang Z; Meng F
    Pulm Pharmacol Ther; 2011 Aug; 24(4):386-93. PubMed ID: 21396478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
    Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of ANP secretion by somatostatin through somatostatin receptor type 2.
    Gao S; Oh YB; Shah A; Park WH; Kim SH
    Peptides; 2011 Jun; 32(6):1179-86. PubMed ID: 21539874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A urotensin II receptor antagonist, KR36676, decreases vascular remodeling and inflammation in experimental pulmonary hypertension.
    Lee JH; Park BK; Oh KS; Yi KY; Lim CJ; Seo HW; Lee BH
    Int Immunopharmacol; 2016 Nov; 40():196-202. PubMed ID: 27611861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
    Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urantide attenuates myocardial damage in atherosclerotic rats by regulating the MAPK signalling pathway.
    Zhao J; Miao G; Wang T; Li J; Xie L
    Life Sci; 2020 Dec; 262():118551. PubMed ID: 33038370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective intracellular calcium handling in monocrotaline-induced right ventricular hypertrophy: protective effect of long-term endothelin-A receptor blockade with 2-benzo[1,3]dioxol-5-yl-3-benzyl-4-(4-methoxy-phenyl-)- 4-oxobut-2-enoate-sodium (PD 155080).
    Brunner F; Wölkart G; Haleen S
    J Pharmacol Exp Ther; 2002 Feb; 300(2):442-9. PubMed ID: 11805203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urantide alleviates the symptoms of atherosclerotic rats in vivo and in vitro models through the JAK2/STAT3 signaling pathway.
    Wang T; Xie L; Bi H; Li Y; Li Y; Zhao J
    Eur J Pharmacol; 2021 Jul; 902():174037. PubMed ID: 33891969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
    Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W
    J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy.
    Tzanidis A; Hannan RD; Thomas WG; Onan D; Autelitano DJ; See F; Kelly DJ; Gilbert RE; Krum H
    Circ Res; 2003 Aug; 93(3):246-53. PubMed ID: 12842917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urotensin inhibition with palosuran could be a promising alternative in pulmonary arterial hypertension.
    Onat AM; Pehlivan Y; Turkbeyler IH; Demir T; Kaplan DS; Ceribasi AO; Orkmez M; Tutar E; Taysi S; Sayarlioglu M; Kisacik B
    Inflammation; 2013 Apr; 36(2):405-12. PubMed ID: 23100033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.